Neurocrine Biosciences, Inc (NBIX) Neurocrine Biosciences Appoints Andrew Ratz, Ph.D., as Chief Technical Operations Officer
Neurocrine Biosciences, Inc (NASDAQ: NBIX) FY 2026 Management Update
18 articles, transcripts, and reports
Neurocrine Biosciences, Inc (NASDAQ: NBIX) FY 2026 Management Update
Neurocrine Biosciences, Inc (NASDAQ: NBIX) Forum
Neurocrine Biosciences, Inc (NASDAQ: NBIX) Q4 2025 Earnings Call dated Feb. 11, 2026 Corporate Participants: Todd Tushla — Vice President...
Neurocrine Biosciences, Inc (NASDAQ: NBIX) FY 2026 Corporate Conference
Neurocrine Biosciences, Inc (NASDAQ: NBIX) FY 2026 Corporate Conference
Neurocrine Biosciences, Inc (NASDAQ: NBIX) Sec Form 10K
Neurocrine Biosciences, Inc (NASDAQ: NBIX) Sec Form 8K
Neurocrine Biosciences, Inc (NASDAQ: NBIX) Q4 2025 Earnings Release
Neurocrine Biosciences, Inc (NASDAQ: NBIX) Q4 2025 Earnings Conference
Neurocrine Biosciences, Inc (NASDAQ: NBIX) Q2 2025 Earnings Call dated Jul. 30, 2025 Corporate Participants: Todd Tushla — Investor Relations Kyle W. Gano — Chief…